8102
-
Core Evidence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Core Evidence
(309,004) Views
Editor in Chief Gulshan Sharma, MD
1555-175X
ReviewEltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
Louise Profit
Core Evidence 2006, 1-Issues 3 & 4:0-0
30 June 2006
Review
Ciclesonide in persistent asthma: the evidence of its therapeutic value
Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
30 June 2006
Rapid Communication
Aripiprazole: the evidence of its therapeutic impact in schizophrenia
William Winlow, Louise Profit, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
30 June 2006
Review
Bortezomib: the evidence of its clinical impact in multiple myeloma
Simon Lancaster
Core Evidence 2006, 1-Issues 3 & 4:0-0
30 June 2006
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
